Study Group: Biopharmaceutical Financial Statement Analysts

Council Members in this Study Group: 30

This study group may include chief financial officers, chartered public accountants, controllers, and consultants knowledgeable on topics such as finance, taxation, auditing, forensic accounting and fraud, financial accounting and reporting, bankruptcy, pension benefits, cash flow, company valuation, working capital, hedge accounting, and mergers and acquisition, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Dan Gode

Co-Founder
Almaris E-Learning Systems

Dan Gode, PhD is Clinical Associate Professor of Accounting, Taxation, and Business Law at New York University Stern School of Business. He is also Co-Founder of Almaris E-Learning Systems. Professor Gode teaches courses in corporate financial accounting...

Eli Bartov

Professor
NEW YORK UNIVERSITY

Eli Bartov, PhD, CPA, is Research Professor of Accounting at the Stern School of Business at New York University. He has authored numerous scholarly articles on issues of accounting earnings manipulations, earnings quality, equity valuation, executive...

Peter Culpepper

Chief Financial Officer
Provectus Pharmaceuticals, Inc.

Peter Culpepper is the Chief Financial Officer and Chief Operating Officer at Provectus Pharmaceuticals. Mr. Culpepper has experience in prescription (therapeutic), biotech, healthcare OTC, specialty pharma, and medical device products. Previous to that,...

Noah Barsky

Director
DI2 Associates, LLC

Noah Barsky, PhD, is a Financial Services Professor at the Villanova University School of Business. He also is Director at DI2 Associates, LLC, a Pennsylvania based accounting and reporting consulting firm. His research and teaching focus on contemporary...

Join this Study Group

Members in this Study Group include these company types:

Pharmaceuticals Manufacturer
Biotechnology Manufacturer
Consulting Firm
Pharmaceuticals/Biotechnology Research Services
Academic Institution*
Independent Consulting Firm
Pharmaceuticals/Biotechnology Research Equipment
Construction Equipment Manufacturer (ei)
Strategic Management
Medical Device Manufacturer

Members in this Study Group often have these job titles:

Chief Financial Officer
Professor
Owner
Accounting Manager
Chief Executive Officer
Consultant
General Manager
Managing Director
Principal

Related Study Groups

Study Group Name	No. Members
Inventory Accounting Experts (US)	25
Chief Financial Officers	2130
Deferred Taxes Academic Specialists	13
Sarbanes-Oxley Specialists	302
FASB 28: Sale-Leaseback Accounting Experts	10
Fraud Accounting Academic Specialists (US)	22
Homebuilder Financial Statement Analysts	24
Homebuilders Industry Accounting Experts	41

GLG Live Meetings with this Study Group's Leading Experts (?)

May 6, 2011 | New York

Seminar: Financial Modeling – Common Mistakes and Salient Issues (New York)

September 10, 2009 | New York

Seminar: Prioritizing Key Value Drivers in a Valuation Model (New York)

August 25, 2009 | New York

Seminar: Merger & Acquisition Accounting (New York)

Webcast: M&A Transactions - Part I (2:00 PM EDT/11:00 AM PDT)

6/1/2010

Play Recording